Biogen Inc. (BIT:1BIIB)

Biogen Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	9,891	9,676	9,836	10,173	10,982
Revenue Growth (YoY)	2.22%	-1.62%	-3.32%	-7.36%	-18.32%
Cost of Revenue	2,404	2,310	2,533	2,278	2,110
Gross Profit	7,486	7,366	7,302	7,895	8,872
Selling, General & Admin	2,434	2,404	2,550	2,404	2,674
Depreciation & Amortization Expenses	515	446.7	240.6	365.9	881.3
Research & Development	2,250	2,042	2,462	2,231	2,519
Other Operating Expenses	425.3	223.7	437.6	-589.1	-43.5
Operating Income	1,862	2,250	1,612	3,484	2,841
Total Non-Operating Income (Expense)	272	227.3	315.5	-402.8	50.7
Pretax Income	1,557	1,906	1,297	3,592	1,745
Provision for Income Taxes	263.6	273.8	135.3	632.8	52.5
Net Income	1,293	1,632	1,161	2,962	1,728
Minority Interest in Earnings	-	-	0.4	-87.9	136.6
Net Income to Common	1,293	1,632	1,161	2,962	1,728
Net Income Growth	-20.79%	40.57%	-60.80%	71.43%	-57.45%
Shares Outstanding (Basic)	147	146	145	145	149
Shares Outstanding (Diluted)	147	146	146	146	150
Shares Change (YoY)	0.82%	0.21%	-0.27%	-2.41%	-7.25%
EPS (Basic)	8.83	11.21	8.02	20.96	10.44
EPS (Diluted)	8.79	11.18	7.97	20.87	10.40
EPS Growth	-21.38%	40.28%	-61.81%	100.67%	-58.06%
Free Cash Flow	2,051	2,722	1,270	1,144	3,382
Free Cash Flow Growth	-24.65%	114.28%	11.03%	-66.17%	-11.12%
Free Cash Flow Per Share	13.94	18.66	8.72	7.84	22.61
Gross Margin	75.69%	76.12%	74.24%	77.61%	80.79%
Operating Margin	18.83%	23.25%	16.39%	34.24%	25.87%
Profit Margin	13.07%	16.87%	11.81%	29.11%	15.73%
FCF Margin	20.73%	28.13%	12.91%	11.25%	30.79%
EBITDA	2,642	2,923	2,107	4,002	3,328
EBITDA Margin	26.71%	30.21%	21.42%	39.34%	30.31%
EBIT	1,862	2,250	1,612	3,484	2,841
EBIT Margin	18.83%	23.25%	16.39%	34.24%	25.87%
Effective Tax Rate	16.94%	14.37%	10.43%	17.62%	3.01%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.